Latest Asx Continuous Disclosure News

Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.

Prestal Holdings Limited posted a 30% drop in sales to $10.3 million and a $3.6 million net loss for FY26, while exiting its core Hampers With Bite business in a strategic pivot.

Acumentis Group Limited (ASX: ACU) has dismissed speculation of undisclosed information behind recent share price and volume surges, pointing instead to its recently reported FY26 financial results showing significant profit growth and a doubled dividend.

Maritana Minerals (ASX:MRT) has reported a 6.3% rise in gold Mineral Resources to 1.86 million ounces and a striking 148% increase in Ore Reserves to 204,100 ounces for FY2026, driven by maiden Ore Reserves at Crake and Kalpini and updates at Boorara.

Arrow Minerals revealed a previously confidential tenement acquisition following an ASX price query triggered by a sharp rise in its share price. The company attributes the price movement to multiple positive developments rather than the acquisition itself.

Australis Oil & Gas (ASX: ATS) has confirmed no undisclosed price-sensitive information following a recent uptick in its share price and volume, attributing market activity to development progress in the Tuscaloosa Marine Shale.

Accent Resources NL confirms no undisclosed information behind recent share price spike, attributing trading activity to positive metallurgical results from its Magnetite Range Project.

American Tungsten & Antimony Ltd (ASX: AT4) affirmed the materiality of its US acquisition deal and detailed its adherence to ASX continuous disclosure rules following an ASX inquiry.

The Agency Group Australia (ASX:AU1) acknowledged ongoing discussions with Aura Group following a spike in share trading and an ASX inquiry. No binding deal is in place, and the company will update the market on material developments.

Synertec Corporation has affirmed that its recent announcements on a $4 million AGL contract and a 40-50% revenue growth forecast for FY27 were material and disclosed promptly, maintaining confidentiality until release.

Advent Energy, via its subsidiary Asset Energy, has formally appealed the Federal Court ruling on the PEP11 gas exploration permit, a move closely watched by BPH Energy, which holds a 35.81% stake in Advent.

HitIQ Limited attributes recent share price and volume spikes to a recent $1.4 million private placement and investor buying, denying any undisclosed material information.